Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. [electronic resource]
Producer: 20010726Description: 1899-910 p. digitalISSN:- 0085-2538
- Animals
- Antihypertensive Agents -- pharmacology
- Base Sequence
- Chromans -- pharmacology
- DNA Primers -- genetics
- Disease Models, Animal
- Glomerulosclerosis, Focal Segmental -- etiology
- Hypoglycemic Agents -- pharmacology
- Insulin Resistance
- Kidney -- pathology
- Lipids -- blood
- Macrophages -- pathology
- Male
- Nephrectomy
- Plasminogen Activator Inhibitor 1 -- genetics
- RNA, Messenger -- genetics
- Rats
- Rats, Sprague-Dawley
- Receptors, Cytoplasmic and Nuclear -- agonists
- Thiazoles -- pharmacology
- Thiazolidinediones
- Transcription Factors -- agonists
- Transforming Growth Factor beta -- genetics
- Troglitazone
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.